2Benmously Mlika Rym, Mokni Mourad, et al. Erythroderma in adults: a report of 80 cases [ J]. International Journal of Dermatology, 2005,44(9) :731 -735.
3Sigurdsson V,de Vfies IJ,Toenstra J,et al. Expression of VCAM - 1, ICAM- 1 E- selectin, and P- selectin on endothelium in situ in patients with erythroderma mycosis fungoides andatopic dermatitis [ J]. Cutan Pathol,2000,27 (9) :436 - 440.
8Karakayli G, Beckham G, Orengo T, et al. Exfoliative dermatitis [J]. Am Fam Physician, 1999(3), 59:625 -630.
9Thestrup - Pedersen K, Halkier - Sorensen L, Sogaard H, et al. The red man syndrome: exfoliative dermatitis of unknown etiology: a description and follow - up of 38 patients [J]. Am Acad Dermatol, 1988,18(6) :1307 - 1312.
10Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Nethenon syndrome [J]. Nat Genet. 2000, 25(2) :141 - 142.
4Sehgal VN, Srivastava G, Sardana K. Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 2004;43:39-47.
5Sigurdsson V, Steegmans PH, Van Vloten WA. Incidence of erythroderma- a survey among all dermatolgists in the Netherlands. J Am Acad Dermatol 2001 ;45:675 - 678.
6Rym BM, Murrad M, Bechir Z, et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol 2005;44:731 -735.
7Sigurdsson V, Toonstra J, Hezemane- Boer M, et al. Erythroderma.J Am Acad Dermatol 1996;35:53- 57.
8Boh EE. Erythroderma in an elderly patient. J Arn Acad Dermatol 2004;51:850 - 852.
9BOTELLA-ESTRADA R,SANMARTIN O,OLIVER V,et al.Erythroderma.A Clinicopathological Study of 56 Cases[J].Arch Dermatol,1994,130(12):1503.
2WONG K C, HO K K. Pemphigus with pemphigoid- like presentation,associated with squamous cell carci- noma of the tongue[J]. Australas J Dermatol,2000, 41:178-180.
3TORO C, RINALDO A, SILVER C E, et al. Paraneo- plastic syndromes in patients with nasopharyngeal cancer[J].Auris Nasus Larynx, 2009,36:513-520.
4BAIJENS L W, MANNI J J. Paraneoplastic syn- dromes in patients with primary malignancies of the head and neck. Four cases and a review of the litera- ture[J].Eur Arch Otorhinolaryngol, 2006, 263: 32-36.
5DEFFER T A, OVERTON-KEARY P P, GOETTE D K. Erythroderma secondary to esophageal carcinoma [J]. J Am Acad Dermatol, 1985,13 (2 Pt 1) : 311 - 313.
7Ruiz D G, Azevedo M N, Santos O L. Psoriatic arthritis: a clinical entity distinct from psoriasis? [J]. Rev Bras Reumatol, 2012,52(4) :630-638.
8Chandran V, Schentag C T, Brockbank J E, et al. Familial aggregation of psoriatic arthritis[J]. Ann Rheum Dis, 2009, 68(5) :664-667.
9Gossec L, Smolen J S, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies [ J ]. Ann Rheum Dis, 2012,71 ( 1 ) :4-12.
10Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study [J]. Arthritis Rheum, 2006,54 ( 8 ) : 2665-2673.
